Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.com 

Rocket Lab is a great company worth owning at a discount, and its elevated volatility pays well to wait for one. It is the only US public rocket company at scale, its backlog grows every quarter and revenue is up 55% year over year. Its implied volatility is among the highest in the space sector, with IV rank above 60%, while weekly EMA clouds are green and daily RSI just hit 44. x.com 

Rocket Lab's $3B at-the-market offering shows it needs investor cash because it has no real earnings or path to profitability, and it should have raised $10-15B while the window lasts. Selling stock at such a high valuation is the only way to sustain the next 18-24 months, and the coming SpaceX IPO will most likely be the sell event for the entire space sector. x.com  x.com 

Rocket Lab can raise capital from a stronger position if better communication wins scarce investor attention. Hiring an experienced content engineer adds that capability alongside its engineering, helping people understand why its products matter. Attention may not directly lift free cash flow per share, but it can lift the stock price and build an engaged investor base for a capital-intensive business. x.com 

Rocket Lab's new $3B at-the-market facility need not hurt the stock, because it has repeatedly raised via ATMs during strength and institutions kept repricing it higher afterward. A quoted post notes the facility is only about 3.7% of market cap and builds a war chest for acquisitions, Neutron, defense and vertical integration, after a record Q1 of $200.3M revenue, up 63.5%, with over $2.2B of backlog. x.com 

Rocket Lab's highly volatile stock leaves some downside risk to the $54 value of its Iridium offer, even with the widened cap-collar range. Rocket Lab did not necessarily overpay compared with the certainty of an all-cash take-private in the mid-$40s, contrary to @OptionTheorist's view that it might have. x.com 

Rocket Lab completing its $1.94 billion ATM to fund the Iridium deal removes an overhang that likely suppressed the whole space sector. As the lead high-beta space name, its ATM selling in a thin, risk-off market was magnified by algos into AST SpaceMobile and peers; that pressure should now ease. After nearly four months of losses from the SpaceX IPO, macro risk-off, low summer liquidity and share sales, a base is starting to form. Delays or macro risk could still weigh. x.com  x.com  x.com 

Rocket Lab's program delays carry a financing cost, not just a later date, because development spending continues while expected customer cash moves out. In a September sensitivity, a $1.25B equity raise at $70 would issue about 17.9M shares, while at $50 it would take 25M, about 7.1M more; this is not a price forecast or a predicted raise. Even with eventual technical success, bridging a longer gap on worse terms could leave existing shareholders owning less of the result. x.com 

Rocket Lab's fundamentals do not yet justify buying, even after a 55% drop took it to around its 200-day moving average. It still lacks positive earnings, net income and growing free cash flow. The upside could be significant if the business executes over the next few years, but more proof of profitability is needed first; it stays on the watch list. x.com  x.com 

Rocket Lab will be a good investment because it does much more than launch rockets, though AST SpaceMobile looks like the better one. x.com